Embracing a new chapter: Per Wallén appointed CEO of Perimed
A new chapter begins at Perimed as Per Wallén assumes the role of Chief Executive Officer, succeeding Lena Åredal.
Get to know Per Wallén
Congratulations! How does it feel to take on the CEO role?
“Thank you — it’s an incredible honor. Perimed is a small Swedish medical technology company with an extensive track record in the global vascular community. I feel deeply committed to the company’s commercial success as well as developing our solutions to adapt to the ever-changing tech space and evolving clinical needs.”
What are your top priorities as CEO in the coming year?
“My immediate focus will be on:
- Raising awareness of the importance of measuring microcirculation.
- Expanding beyond our traditional vascular segments to secure long-term growth.
- Growing our commercial teams in our major markets.
How do you see Perimed evolving over the next 3–5 years?
“Over the next 5 years, we aim to double turnover. One of the ways we will achieve this is through deeper penetration in major markets, like the US, Germany, and the UK. We will deliver some sought-after developments in our product capabilities, investigate new business models, and explore the potential of cloud computing. As with all tech-related businesses, cybersecurity and AI are top priorities for us.”
What trends are you currently following?
“The first one relates to the ever-rising prevalence of conditions such as diabetes and peripheral artery disease (PAD), due in part to aging populations, lifestyle changes, and obesity. I can’t emphasize enough the critical role that microcirculation plays in the diagnosis and treatment of these diseases — yet it often remains under-assessed in clinical practice. That’s why it’s so significant that Perimed offers the only FDA 510(k)-cleared device capable of assessing both macro- and microcirculation in a single system.
And the second one is healthcare spending. Since the COVID-19 pandemic, we’ve seen a tightening of global healthcare budgets. Therefore, Perimed is investing in health economic studies with emphasis on early assessment and diagnosis. Investing in capital equipment becomes a much easier decision when you can demonstrate a reduction in the total cost of care with improved quality of life.”
One thing people might not know about you as a leader?
“Earlier in my career, I served as a Lieutenant in the Swedish Navy, with formal training in anti-submarine warfare. That experience taught me the importance of preparation, clear communication, and decisive action — qualities that are just as essential in business leadership as they are in naval operations.”
A word from the Board
Per’s appointment marks a defining moment for Perimed and was selected by the Perimed Board of Directors. Here is the board’s motivation:
“Per Wallén has a stellar track record in commercial roles in medical device sales and previous experience as Managing Director. In addition, Per has excelled in his commercial leadership, focus, and impact since joining Perimed as the VP of Sales & Marketing last year. On behalf of the Board of Directors, I am confident that Per is the ideal candidate to lead the next chapter in Perimed’s history. At the same time, we would like to thank Lena Åredal for her contribution as CEO over the past four years.”
—Björn Bakken, Chairman of the Board
For more about Per, visit his LinkedIn profile: Per Wallén